Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vvi16g0822 ATGATGATGGCGTTTAAGCTTGTGTGCTTTCATCTCTTTGTGTTTCAGCTTCTTTTCTGTGTCTCCAACGCCATTGCTGACCAAAATGGAGAAGACCCAGAAGCCAAACTACTCATTTCTTTCAAAAATGCTCTTCAAAACCCTCAAATGCTCTCTTCATGGAACTCTACCGTTTCTCGCTGTCAATGGGAAGGTGTGCTTTGCCAGAACGGCCGAGTCACCTCACTCGTCCTCCCTACTCAATCCCTCGAGGGTGCTCTCTCTCCTTCTCTCTTTTCTCTTTCCAGCCTCATTGTCCTCGACCTCTCCGGCAACCTTTTCTCCGGTCATCTTTCGCCGGACATTGCCGGGCTGCGGCGGTTGAAGCACTTGTTACTGGGTGATAATGAACTATCGGGTGAGATTCCTCGTCAACTAGGTGAGTTGACTCAGCTGGTGACTCTGAAACTCGGTCCTAACTCGTTTATTGGGAAAATCCCTCCGGAGCTTGGAGACCTGACGTGGCTGCGGTCTCTCGACCTCTCTGGCAACTCCCTGACGGGAGACCTGCCGACTCAGATCGGAAACTTGACCCATCTCCGGTTACTTGACGTCGGCAACAACCTTCTCTCAGGTCCTCTCTCTCCAACTCTCTTCACAAATCTTCAGTCTTTAATCTCTCTTGACGTTTCAAACAACTCGTTTTCCGGAAATATTCCGCCGGAAATAGGTAACTTAAAGAGCCTGACTGATCTTTACATTGGTATCAACCACTTTTCCGGCCAGTTACCACCGGAAATCGGTAATCTTTCGAGTCTGCAGAACTTCTTTTCACCATCGTGTTCCATTAGAGGTCCATTGCCGGAGCAAATCTCTGAGCTGAAATCACTGAATAAACTTGATCTTTCCTATAACCCACTCAAGTGTTCGATCCCAAAATCTATTGGGAAGTTGCAGAACTTGACAATACTGAACTTTGTCTATGCCGAGCTCAATGGTTCGATTCCGGCGGAGCTCGGAAAGTGCCGGAATTTAAAGACATTGATGCTTTCTTTCAACTCCATCTCCGGGTCATTGCCGGAGGAGCTTTCAGAGCTCCCAATGCTGTCATTTTCTGCTGAAAAGAATCAGCTATCAGGGCCATTGCCTTCTTGGCTTGGAAAATGGAATGGGATTGATTCCCTTCTGCTTTCAAGTAATCGGTTTTCTGGGAGGATCCCACCTGAGATTGGGAATTGTTCTATGCTTAATCACGTTAGCTTGAGTAATAACTTGTTATCTGGTTCAATTCCGAAGGAGCTTTGTAACGCAGAGTCGCTAATGGAGATTGATTTGGATAGTAATTTTCTTTCTGGGGGTATAGATGATACGTTTTTGAAGTGTAAAAACCTGACCCAGTTGGTTTTGGTGAATAACCAGATTGTTGGCTCCATACCTGAGTACCTCTCAGAGCTTCCTTTGATGGTTCTTGACCTTGATTCGAACAATTTCACGGGTTCTATACCTGTGAGTCTGTGGAACTTGGTGAGTTTGATGGAGTTTTCAGCTGCAAATAATCTCCTGGAGGGTTCTCTCCCACCAGAGATTGGCAATGCGGTTGCGTTGGAGAGGCTTGTTCTTAGTAACAACCGGTTGAAGGGCACAATACCTAGGGAGATTGGAAATTTGACATCCCTGTCTGTTCTTAATTTGAATTTAAATCTGCTTGAAGGGATTATTCCAATGGAGCTTGGTGATTGCATTTCACTCACTACATTGGACCTTGGAAACAACCTTCTCAATGGGTCAATTCCTGATAGAATTGCGGATTTGGCACAGCTTCAGTGTCTGGTTCTTTCTCACAATGACTTATCTGGATCCATTCCTTCAAAACCATCTTCTTATTTTCGTCAGGTCAATATTCCTGATTCAAGCTTTGTTCAGCACCATGGAGTATATGATCTGTCCTATAATAGACTGTCTGGTTCAATACCTGAAGAGTTAGGGAGCTGTGTGGTGGTGGTGGATCTTCTACTCAGCAATAACTTTCTTTCAGGAGAGATTCCAATCTCTCTCTCCCGGCTAACCAACCTTACAACCTTGGATTTATCTGGGAATTTGCTGACTGGTTCCATTCCATTGAAATTGGGCTACTCTCTTAAGCTCCAAGGCTTGTATCTGGGGAATAACCAGCTCACTGGCACCATCCCAGAAAGCTTAGGACGATTGAGTAGTTTGGTAAAGCTGAATTTGACAGGTAATCAGCTGTCCGGTTCAATCCCATTCAGCTTTGGGAACTTGACTGGGCTCACCCACTTTGATTTAAGTTCCAATGAACTTGATGGTGAGCTCCCTTCGGCTCTTTCGAGCATGGTGAACCTTGTTGGGCTCTATGTGCAGCAGAACAGGCTTTCAGGTCAGGTCAGTAAGCTGTTTATGAATTCCATTGCATGGAGAATCGAAACATTAAACTTGAGTTGGAATTTCTTCAATGGAGGATTGCCAAGGTCTTTGGGCAATCTATCATACTTGACCAATTTGGATCTTCATCACAACATGTTTACTGGGGAGATTCCCACGGAGCTTGGGGACCTTATGCAGCTTGAGTATTTTGATGTTTCAGGTAATAGGCTTTGTGGGCAAATTCCAGAGAAGATATGCAGCCTTGTCAATCTGCTTTACCTGAATTTGGCCGAAAATAGATTGGAAGGCTCTATACCTAGAAGTGGTGTTTGCCAAAACCTATCCAAAGATTCACTGGCTGGTAACAAAGATTTGTGTGGAAGAAACCTTGGTTTAGAATGCCAATTCAAGACCTTTGGTAGAAAATCTTCATTGGTAAACACCTGGGTACTTGCAGGGATTGTTGTGGGATGTACTCTCATCACCCTAACTATTGCTTTTGGTCTTCGGAAATGGGTTATCAGAAACAGCAGGCAAAGCGATACAGAAGAGATTGAGGAAAGCAAATTAAACAGCTCTATAGATCAAAATCTCTACTTCTTAAGCAGCAGCAGATCAAAGGAGCCTCTTAGCATCAACGTGGCCATGTTCGAGCAGCCTCTGCTAAAACTGACTTTAGTCGATATCCTTGAAGCCACCAACAATTTCTGCAAGACAAACGTGATTGGAGATGGAGGCTTTGGAACTGTCTACAAAGCTGCTTTACCTAACGGAAAAATAGTTGCAGTCAAGAAGCTAAACCAAGCCAAGACACAGGGTCATCGAGAATTTCTGGCAGAAATGGAAACTCTAGGTAAGGTCAAGCACAGAAACCTTGTACCCCTGCTGGGGTACTGCTCTTTTGGTGAGGAGAAGTTTCTAGTATACGAGTATATGGTAAATGGGAGCTTGGATCTATGGCTGAGGAACCGCACTGGGGCTCTTGAAGCCTTGGACTGGACAAAACGCTTCAAAATTGCAATGGGGGCGGCTCGTGGGCTAGCATTTCTTCACCATGGCTTCATCCCCCACATCATTCACCGCGACATTAAAGCCAGCAACATCTTGCTGAACGAAGACTTTGAGGCGAAAGTTGCAGACTTTGGGCTGGCGAGGTTGATCAGTGCCTGTGAAACTCATGTGAGTACCGACATAGCTGGGACGTTCGGGTACATTCCACCAGAGTATGGCCTAAGCTGGAGGTCTACAACAAGGGGGGACGTCTACAGTTTTGGAGTGATTCTGCTGGAACTGGTTACTGGGAAGGAGCCAACAGGACCTGATTTCAAGGACTTTGAAGGAGGGAATCTAGTGGGGTGGGTGTTTGAGAAGATGAGGAAGGGTGAGGCTGCAGAAGTGCTGGATCCAACGGTTGTGAGGGCGGAATTGAAGCACATAATGCTTCAAATTCTGCAGATTGCTGCAATATGCCTATCTGAAAATCCAGCTAAAAGGCCTACCATGCTTCATGTGTTGAAGTTTCTGAAAGGGATCAAAGATGAGTGA 3906 0.4539 MMMAFKLVCFHLFVFQLLFCVSNAIADQNGEDPEAKLLISFKNALQNPQMLSSWNSTVSRCQWEGVLCQNGRVTSLVLPTQSLEGALSPSLFSLSSLIVLDLSGNLFSGHLSPDIAGLRRLKHLLLGDNELSGEIPRQLGELTQLVTLKLGPNSFIGKIPPELGDLTWLRSLDLSGNSLTGDLPTQIGNLTHLRLLDVGNNLLSGPLSPTLFTNLQSLISLDVSNNSFSGNIPPEIGNLKSLTDLYIGINHFSGQLPPEIGNLSSLQNFFSPSCSIRGPLPEQISELKSLNKLDLSYNPLKCSIPKSIGKLQNLTILNFVYAELNGSIPAELGKCRNLKTLMLSFNSISGSLPEELSELPMLSFSAEKNQLSGPLPSWLGKWNGIDSLLLSSNRFSGRIPPEIGNCSMLNHVSLSNNLLSGSIPKELCNAESLMEIDLDSNFLSGGIDDTFLKCKNLTQLVLVNNQIVGSIPEYLSELPLMVLDLDSNNFTGSIPVSLWNLVSLMEFSAANNLLEGSLPPEIGNAVALERLVLSNNRLKGTIPREIGNLTSLSVLNLNLNLLEGIIPMELGDCISLTTLDLGNNLLNGSIPDRIADLAQLQCLVLSHNDLSGSIPSKPSSYFRQVNIPDSSFVQHHGVYDLSYNRLSGSIPEELGSCVVVVDLLLSNNFLSGEIPISLSRLTNLTTLDLSGNLLTGSIPLKLGYSLKLQGLYLGNNQLTGTIPESLGRLSSLVKLNLTGNQLSGSIPFSFGNLTGLTHFDLSSNELDGELPSALSSMVNLVGLYVQQNRLSGQVSKLFMNSIAWRIETLNLSWNFFNGGLPRSLGNLSYLTNLDLHHNMFTGEIPTELGDLMQLEYFDVSGNRLCGQIPEKICSLVNLLYLNLAENRLEGSIPRSGVCQNLSKDSLAGNKDLCGRNLGLECQFKTFGRKSSLVNTWVLAGIVVGCTLITLTIAFGLRKWVIRNSRQSDTEEIEESKLNSSIDQNLYFLSSSRSKEPLSINVAMFEQPLLKLTLVDILEATNNFCKTNVIGDGGFGTVYKAALPNGKIVAVKKLNQAKTQGHREFLAEMETLGKVKHRNLVPLLGYCSFGEEKFLVYEYMVNGSLDLWLRNRTGALEALDWTKRFKIAMGAARGLAFLHHGFIPHIIHRDIKASNILLNEDFEAKVADFGLARLISACETHVSTDIAGTFGYIPPEYGLSWRSTTRGDVYSFGVILLELVTGKEPTGPDFKDFEGGNLVGWVFEKMRKGEAAEVLDPTVVRAELKHIMLQILQIAAICLSENPAKRPTMLHVLKFLKGIKDE* 1302
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vvi16g0822 1301 Pfam Leucine rich repeat 682 742 IPR001611 GO:0005515
Vvi16g0822 1301 SUPERFAMILY L domain-like 42 363 - -
Vvi16g0822 1301 SMART serkin_6 1023 1295 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vvi16g0822 1301 Gene3D Ribonuclease Inhibitor 271 364 IPR032675 -
Vvi16g0822 1301 Gene3D Ribonuclease Inhibitor 365 511 IPR032675 -
Vvi16g0822 1301 SMART LRR_typ_2 287 311 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 753 777 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 875 900 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 827 851 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 215 239 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 549 572 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 729 752 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 681 705 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 335 359 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 166 189 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 190 214 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 118 142 IPR003591 -
Vvi16g0822 1301 SMART LRR_typ_2 94 117 IPR003591 -
Vvi16g0822 1301 FunFam leucine-rich repeat receptor protein kinase EMS1 213 362 - -
Vvi16g0822 1301 Gene3D Ribonuclease Inhibitor 631 924 IPR032675 -
Vvi16g0822 1301 Gene3D Phosphorylase Kinase; domain 1 985 1098 - -
Vvi16g0822 1301 Pfam Leucine Rich Repeat 169 189 IPR001611 GO:0005515
Vvi16g0822 1301 Pfam Leucine Rich Repeat 290 311 IPR001611 GO:0005515
Vvi16g0822 1301 Pfam Leucine Rich Repeat 806 827 IPR001611 GO:0005515
Vvi16g0822 1301 SUPERFAMILY L domain-like 368 620 - -
Vvi16g0822 1301 SUPERFAMILY L domain-like 634 916 - -
Vvi16g0822 1301 Pfam Leucine rich repeat N-terminal domain 32 68 IPR013210 -
Vvi16g0822 1301 FunFam Leucine-rich repeat family protein 33 187 - -
Vvi16g0822 1301 FunFam serine/threonine-protein kinase BRI1-like 2 984 1098 - -
Vvi16g0822 1301 ProSiteProfiles Protein kinase domain profile. 1023 1301 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vvi16g0822 1301 Pfam Protein tyrosine and serine/threonine kinase 1026 1295 IPR001245 GO:0004672|GO:0006468
Vvi16g0822 1301 Gene3D Transferase(Phosphotransferase) domain 1 1099 1301 - -
Vvi16g0822 1301 Gene3D Ribonuclease Inhibitor 512 630 IPR032675 -
Vvi16g0822 1301 Gene3D Ribonuclease Inhibitor 184 270 IPR032675 -
Vvi16g0822 1301 ProSitePatterns Serine/Threonine protein kinases active-site signature. 1145 1157 IPR008271 GO:0004672|GO:0006468
Vvi16g0822 1301 PANTHER UNNAMED PRODUCT 7 108 - -
Vvi16g0822 1301 FunFam serine/threonine-protein kinase BRI1-like 2 1099 1301 - -
Vvi16g0822 1301 PRINTS Leucine-rich repeat signature 169 182 - -
Vvi16g0822 1301 PRINTS Leucine-rich repeat signature 681 694 - -
Vvi16g0822 1301 ProSitePatterns Protein kinases ATP-binding region signature. 1029 1052 IPR017441 GO:0005524
Vvi16g0822 1301 FunFam Uncharacterized protein 363 627 - -
Vvi16g0822 1301 Gene3D Ribonuclease Inhibitor 31 183 IPR032675 -
Vvi16g0822 1301 SMART LRR_sd22_2 287 308 - -
Vvi16g0822 1301 SMART LRR_sd22_2 753 782 - -
Vvi16g0822 1301 SMART LRR_sd22_2 681 702 - -
Vvi16g0822 1301 SMART LRR_sd22_2 166 192 - -
Vvi16g0822 1301 SMART LRR_sd22_2 335 358 - -
Vvi16g0822 1301 SMART LRR_sd22_2 454 477 - -
Vvi16g0822 1301 SMART LRR_sd22_2 851 877 - -
Vvi16g0822 1301 SUPERFAMILY Protein kinase-like (PK-like) 1004 1295 IPR011009 -
Vvi16g0822 1301 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 629 925 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vvi16g0822 Vvi-Chr16 16185826 16189731 Dispersed/Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vvi16g0822 34 772 Receptor kinase-like Gene Family AT5G07280 37.564 1.19e-108 369
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-Xb-1 Vvi16g0822 PK_Tyr_Ser-Thr 3.9e-46 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vvi16g0822 - - vvi:100260549 2501.09